MedTrace Logo

Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery

NCT07105904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-04-20

No results posted yet for this study

Summary

The goal of this observational study is to assess the correlation between Quantra viscoelastometric assay and laboratory hemostasis biology in a cardiac surgery cohort presenting with acute hemorrhage in the operating room. The main questions it aims to answer are:

* is Quantra a valuable surrogate for hemostasis biology in the setting of bleeding cardiac surgery?
* are Quantra parameters well correlated with tranfusion thresholds in the setting of bleeding cardiac surgery?

Conditions

Interventions

DIAGNOSTIC_TEST

Viscoelastometric hemostatic assay

As part of usual care, when weaning the patient from CPB during cardiac surgery, blood samples are withdrawn from the patient to assess hemostasis: we test both Quantra viscoelastometric assay and biological hemostasis including QT, ACT, fibrinogen and platelet count

Sponsors & Collaborators

  • Pitié-Salpêtrière Hospital

    lead OTHER

Principal Investigators

  • Adrien Bouglé, Md, PhD · Pitié-Salpêtrière Hospital

  • Geoffroy Hariri, MD · Pitié-Salpêtrière Hospital

  • Pierre Basse, MD · Pitié-Salpêtrière Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-10
Primary Completion
2026-02-15
Completion
2026-03-15
FDA Device
Yes

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07105904 on ClinicalTrials.gov